University of California, Davis
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).
University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.
University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
657 total, page 11 of 14
Probiotics in Infants With Gastroschisis
NCT01316510
Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients
NCT01270854
The Effect of Food Taste, Temperature, and Viscosity on Swallowing Efficiency
NCT01270204
Behavior and Driving Safety Study II
NCT01270217
Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
NCT01316523
Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer
NCT01261299
Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis
NCT01852032
Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis
NCT01365793
Effects of the Consumption of California Walnuts on Cardiovascular Health
NCT01235390
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
NCT01820234
ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
NCT01213082
Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease
NCT03174990
The Effect of Whole Beans on Inflammation and Satiety
NCT01190384
Grape Seed Extract and Postprandial Oxidation and Inflammation
NCT01190358
Soy Nut Study on Markers of Health
NCT01173380
Safety and Efficacy of PCI at California Hospitals Without Onsite Cardiac Surgery
NCT02022345
Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study
NCT01144104
Effects of California Walnuts on Vascular Function in Postmenopausal Women
NCT01072864
Skin Lipid Profiles in Term and Preterm Infants
NCT01841268
Prevention of Overfeeding During Infancy
NCT01043978
Assessment of an Intervention to Prevent Obesity and Diabetes in Latino Farm Workers
NCT01855282
Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms
NCT01110174
The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery
NCT01683448
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors
NCT01072890
Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities
NCT00786747
Trial of Minocycline to Treat Children With Fragile X Syndrome
NCT01053156
Effects of Vaporized Marijuana on Neuropathic Pain
NCT01037088
Evaluation of Two Different Thickening Products in Patients With Dysphagia
NCT01651975
Probiotics in Infants With Cyanotic Congenital Heart Disease
NCT01018472
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
NCT01053286
Letrozole as a Treatment of Endometrial Cancer
NCT00997373
Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis
NCT00985894
Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis
NCT00918645
Delayed Cord Clamping in Premature Infants
NCT01018576
Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy
NCT00986310
Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis
NCT00971477
Comprehensibility of Colorectal Cancer Screening Educational Materials: Effects on Patient Knowledge and Motivation
NCT00965965
Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors
NCT00804310
Use of Portable Technology in Patient Education of Shave/Punch Biopsies
NCT01110148
The Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants
NCT00810160
Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy
NCT00895310
Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
NCT00810719
Pilot Study of Lychee Fruit Extract to Promote Cardiovascular Health
NCT01162213
A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy
NCT00870363
The First Therapeutic Intervention in Malignant Pleural Effusion Trial
NCT00896285
Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall
NCT00864032
Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors
NCT00807755
Family Research Study: Metabolism of Fats and Proteins in Specific Ethnic Groups
NCT00853775
Electrodermabrasion Compared to Dermabrasion
NCT01769989
CCRC: Understanding the Effects of Omega-3 Fatty Acids Versus Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease
NCT00935922
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 43 |
| Phase 3 | 10 |
| Phase 4 | 28 |
Therapeutic Areas
What is open in the University of California, Davis pipeline
123 recruiting of 657 indexed (19% open); 435 completed (66%).
Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Healthy (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Davis: open-pipeline peers nationwide
Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 657 trials (± recruiting share)
- Vanderbilt University Medical Center · 677 trials · 19% recruiting
- University of Rochester · 636 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
- Insulet Corporation · 19% recruiting · 16 trials
- Medical University of South Carolina · 19% recruiting · 755 trials
Related
What to do with this University of California, Davis page
657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.
- 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Davis pipeline card: 657 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.